The Enforcement Directorate (ED) has made significant strides in an ongoing investigation into a major bank loan fraud case, conducting extensive search operations in Mumbai and Yamunanagar, Haryana. On Friday, the agency executed raids at eight locations, which led to the seizure of movable assets, including bank funds and Demat accounts, amounting to a staggering ₹14.53 crore. The searches are part of an investigation into the actions of Sharon Bio Medicine Limited and several individuals associated with the company, including Mohan Prasad Kala, Savita Satish Gowda, and Lalit Shambu Misra, under the Prevention of Money Laundering Act (PMLA) of 2002.
During these search operations, the ED recovered various incriminating documents, digital devices, and paperwork related to immovable properties, which are believed to be crucial to the investigation. The agency's efforts are focused on uncovering the full extent of the alleged fraud, which is linked to a broader case initiated by the Central Bureau of Investigation (CBI) and the Anti-Corruption Bureau (ACB) in Mumbai. These agencies had previously registered a case against Sharon Bio Medicine Limited and its associates, citing various violations of the Indian Penal Code (IPC) and the Prevention of Corruption Act of 1988.
According to the ED's findings, Sharon Bio Medicine Limited (SBML) is a pharmaceutical company that purportedly engaged in fraudulent activities to secure loans from various banks, causing financial losses estimated at ₹220 crore. The company allegedly employed forged documents and bogus contracts to avail itself of credit facilities, diverting and siphoning off funds for asset creation rather than legitimate business operations.
The investigation has revealed a complex scheme wherein SBML allegedly created a network of shell companies. These entities facilitated bogus sales and purchases, artificially inflating SBML's turnover. The company is accused of providing false contracts and fraudulent documentation to banks to secure and enhance its credit facilities. After acquiring these loans, funds were allegedly funneled through multiple layers of these shell companies, which were ostensibly owned by employees of SBML and relatives of key personnel associated with the firm.
The ED officials have stated that further investigation is ongoing, as they continue to unravel the intricacies of this elaborate fraud scheme. The agency's actions underscore its commitment to combating financial crimes and enforcing the rule of law in financial dealings, especially within the corporate sector. As the investigation progresses, the ED is expected to gather more evidence that could lead to further actions against those involved in the fraudulent activities associated with Sharon Bio Medicine Limited.
Â
